SYNTHESIS AND BIOLOGICAL PROPERTIES OF 2-FLUORONOREPINEPHRINES, 5-FLUORONOREPINEPHRINES, AND 6-FLUORONOREPINEPHRINES

被引:85
作者
KIRK, KL
CANTACUZENE, D
NIMITKITPAISAN, Y
MCCULLOH, D
PADGETT, WL
DALY, JW
CREVELING, CR
机构
[1] Laboratories of Bioorganic Chemistry and Chemistry, National Institute of Arthritis, Metabolism and Digestive Diseases, National Institutes of Health, Bethesda
关键词
D O I
10.1021/jm00198a012
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
2-Fluoro-, 5-fluoro-, and 6-fluorodimethoxybenzaldehydes were prepared by photochemical decomposition of the corresponding diazonium fluoroborates. The aldehydes were converted to the cyanohydrin trimethylsilyl ethers, which, in turn, were reduced to the dimethoxyphenethanolamines. Boron tribromide demethylation afforded the racemic ring-fluorinated norepinephrines. An alternate route, using the dibenzyloxyfluoroaldehyde, was also used to prepare 6-fluoronorepinephrine. The fluorine substituent markedly increases the phenolic acidities of these analogues. The biological properties conferred upon norepinephrine by the fluorine substituents in peripheral and central adrenergically responsive systems clearly demonstrate that 2-fluoronorepinephrine is a nearly pure β-adrenergic agonist, while 6-fluoronorepinephrine is an α-adrenergic agonist. 5-Fluoronorepinephrine retains both β-and α-adrenergic agonist properties. Receptor-binding studies with specific radiolabeled ligands indicate that the specificity conferred by the site of fluorine substituents results from a change in the affinity of these analogues for the α-and (β-adrenergic. © 1979, American Chemical Society. All rights reserved.
引用
收藏
页码:1493 / 1497
页数:5
相关论文
共 39 条
  • [1] A STUDY OF THE ADRENOTROPIC RECEPTORS
    AHLQUIST, RP
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1948, 153 (03): : 586 - 600
  • [2] DIRECT IDENTIFICATION AND CHARACTERIZATION OF BETA-ADRENERGIC RECEPTORS IN RAT-BRAIN
    ALEXANDER, RW
    DAVIS, JN
    LEFKOWITZ, RJ
    [J]. NATURE, 1975, 258 (5534) : 437 - 440
  • [3] BECKER ED, 1969, HIGH RESOLUTION NMR, P152
  • [4] BENNETT JP, 1978, NEUROTRANSMITTER REC, P57
  • [5] BYLUND DB, 1976, MOL PHARMACOL, V12, P568
  • [6] EFFECT OF FLUORINE SUBSTITUTION ON THE AGONIST SPECIFICITY OF NOREPINEPHRINE
    CANTACUZENE, D
    KIRK, KL
    MCCULLOH, DH
    CREVELING, CR
    [J]. SCIENCE, 1979, 204 (4398) : 1217 - 1219
  • [7] MODIFICATION OF PARKINSONISM - CHRONIC TREATMENT WITH L-DOPA
    COTZIAS, GC
    PAPAVASI.PS
    GELLENE, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (07) : 337 - &
  • [8] CREVELING C, 1979, TRANSMETHYLATION, P269
  • [9] CHEMORELEASE OF NOREPINEPHRINE FROM MOUSE HEARTS .3. 3,5-DIHYDROXY-4-METHOXYPHENETHYLAMINES AND RELATED COMPOUNDS
    CREVELING, CR
    DALY, JV
    WITKOP, B
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1968, 11 (03) : 595 - +
  • [10] CREVELING CR, 1979, FED PROC, V38, P251